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Abstract The glycosphingolipid patterns were analyzed on two 
clones derived from a human melanoma cell line and selected for 
their respectively high and low metastatic ability in immunosup- 
pressed newborn rats. Conversely to the weakly metastatic ells 
which exhibited a pattern similar to that of the parental cell line, 
highly metastatic human melanoma cells appeared to be deficient 
in ganglioside biosynthesis. An accumulation of lactosylceramide 
was found in the latter cells, with low amounts of GM3 as the only 
ganglioside detected and a fourfold decreased activity of GM3 
synthase (EC 2.4.99.9). After subcutaneous injection of metas- 
tatic cells in newborn rats, the cells proliferating in the tumor 
induced at the injection site re-expressed the four common gangli- 
osides of melanoma: GM3, GM2, GD3 and GD2, whereas the 
cells growing in the lungs as metastatic nodules were deficient in 
ganglioside synthesis and showed an accumulation of lactosylcer- 
amide. Taken together, our results suggest hat the human mela- 
noma cells which are able to escape from the primary tumor and 
invade the lungs have an impaired ganglioside biosynthesis with 
a deficient GM3 synthase. 
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I. Introduction 
Gangliosides are ubiquitous membrane-associated sialic 
acid-containing glycosphingolipids implicated in a broad range 
of biological functions. Their location on the outer leaflet of the 
lipid bilayer of the plasma membrane make them specific medi- 
ators for cellular adhesion and intercellular recognition phe- 
nomena [1,2] involved in the multi-step rocess of the metas- 
tatic diffusion of cancer cells [3]. Although ganglioside patterns 
exhibit cellular lineage-dependant specificity [4], changes in the 
structure, synthesis and cell surface exposure of glycosphingo- 
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lipids are associated with metastatic phenotype in various ex- 
perimental tumor systems [5-7]. 
Human melanoma tissues and cell lines express GM3, GM2, 
GD3 and GD2 as major gangliosides, whereas normal mela- 
nocytes essentially synthesize GM3 ganglioside [8 10]. Mouse 
and human monoclonal antibodies (MAbs) to disialogangli- 
osides GD2 and GD3 have thus been used in clinical trials to 
treat melanoma patients [11 13]. In the same way, active immu- 
notherapeutical trials using ganglioside vaccines have been con- 
ducted [14-16]. However, little is known about he gangliosides 
exposed on human malignant melanocytes that are able to 
escape from the primary tumor to establish distant metastases. 
We recently reported evidence suggesting that deficient sia- 
lylation of glycoproteins i  involved in the metastatic capacity 
of human malignant melanocytes [17]. In a spontaneous metas- 
tasis model of human melanoma recently established in our 
laboratory [18,19], PNA-binding lycoproteins are expressed in
human melanoma cells able to give lung metastases whereas 
these cell surface glycoproteins in non-metastatic cells are sia- 
lylated and do not bind PNA lectin [20]. Sialyltransferases 
being also essential enzymes in the biosynthesis ofgangliosides, 
we determined the patterns of gangliosides ofmetastatic (T1 C3) 
and non-metastatic (IC8) clones of our melanoma model, as 
well as those of the corresponding tumors grown in immuno- 
suppressed newborn rats. The present data indicate that human 
melanoma cells able to give lung metastases are defective in 
ganglioside biosynthesis and accumulate their common precur- 
sor, lactosylceramide (LacCer) because of a lowered activity of 
CMP-NeuAc: LacCer a2-3 sialyltransferase (EC 2.4.99.9). 
2. Materials and methods 
2.1. Reference compounds and reagents 
Gangliosides GM3, GM2, GD3 and GD2 were purified from human 
melanoma tumors [16]. Glycosphingolipids: CMH and CTH were puri- 
fied from human thyroid tumors [21]. Lactosylceramide (LacCer), used 
for CMP-NeuAc:LacCer a2-3 sialyltransferase (EC 2.4.99.9) assay 
was isolated from human melanoma tissue and shown to be pure ac- 
cording to the procedure previously described [22]. CMP-[~4C]NeuAc 
was purchased from Amersham (Les Ulis, France, 10.5 GBq/mmol). 
Anti-thymocyte s rum (ATS) was prepared according to Bailly et al. 
[19]. 
2.2. Cells and cell culture 
Two clones (IC8 and T1C3) derived from M4Be human melanoma 
cell line were used in this study. The procedures for selection and 
cloning and the culture conditions have been described elsewhere [18, 
20]. Cell cultures were regularly tested for absence of mycoplasma and 
preserved metastatic capability. The metastasis incidence and the num- 
ber of lung nodules in immunosuppressed newborn rats were assessed 
using a standardized protocol as described [18,19]. 
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Fig. 1. HPTLC patterns of gangliosides (A) and neutral glycosphingolipids (B) extracted from the low metastatic parental human melanoma cell 
line M4Be (a) and IC8 clone (b) and from the high metastatic T1C3 clone (c). Glycosphingolipids corresponding to 2 mg cellular proteins were 
chromatographed on HPTLC plates and visualized by spraying with orcinol-sulfuric acid. Migrations of reference glycosphingolipids are indicated 
on the left. 9-O-AcGD3 migrated just below GM2. In panel A, bands above GM3 are residual neutral glycosphingolipids. In panel B, GM3 and 
bands below are resorcinol-positive (not shown). 
2.3. Tumors and metastases 
In vivo experiments were performed according to Bailly et al. [18,19]. 
Briefly, newborn rats less than 24 hours old received simultaneously an
s.c. injection of 0.1 ml melanoma cell suspension ( 106 cells) in the ventral 
area and an optimal dose of anti-thymocyte s rum (ATS) in the dorsal 
area. ATS injection was repeated on days 2, 7 and 14 and the animals 
were killed on day 21. Surgical excision was performed on s.c. tumors 
that were growing at the injection site with all clones regardless of their 
metastatic potential, and the lungs were collected for anatomo-pa- 
thological examination. 
2.4. Glycosphingolipid extraction 
Gangliosides and neutral glycosphingolipids from cultured mela- 
noma cells, rat s.c. tumors, and rat lungs were isolated according to a 
procedure already described [23]. The glycosphingolipids remaining in 
the lower phase of partition were purified by the acetylation procedure 
of Saito and Hakomori [24]. 
2.5. Thin-layer chromatograph), 
The gangliosides and neutral glycosphingolipids were separated by 
thin-layer chromatography onaluminium-backed silica gel 60 HPTLC 
plates (Merck, Darmstadt, Germany), using as solvent systems chloro- 
form/methanol/0.2% aqueous CaCI 2, 55:45 :10 (by vol.) or chloroform/ 
methanol/water, 65:25:4. The glycosphingolipids were visualized by 
spraying with orcinol-sulfuric acid and heating at 160°C. They were 
identified by comigration with reference compounds and by immunode- 
tection on thin-layer plates as described [25] using specific mouse mon- 
oclonal antibodies (MAbs). MAbs GMR6 (IgM) directed to GM3 
ganglioside and GMB28 (IgM) to GM2 [26] were kindly provided by 
Dr. Tadashi Tai (Tokyo Metropolitan Institute of Medical Science). 
MAbs 4G2 (IgG3) to GD2 [27], 4F6 (IgG3) reactive with GD3 and 7H2 
(IgG2a) specific for O-acetylGD3 were produced in our laboratory. 
Their relative amount was estimated by scanning the HPTLC plates on 
a CS-930 Chromatoscan densitometer (Shimadzu, Kyoto, Japan). 
2.6. CMP-NeuAc: LacCer a2-3 sialyltransferase (GM3 synthase. 
EC 2.4. 99. 9) assay and characterization of the reaction 
products 
Subconfluent monolayer cells were mechanically disrupted, rinsed 
twice with PBS and centrifuged at 1800 rpm for 10 min. Cell pellets were 
resuspended in a cold 10 mM sodium cacodylate buffer, pH 6.5 contain- 
ing 1% Triton CF-54, 20% glycerol and 0.5 mM dithiothreitol. After 
centrifugation at 4°C for 15 min at 10,000 ×g, the supernatant was 
assayed for protein concentration and GM3 synthase activity. GM3 
synthase activity was determined in duplicates using a procedure mod- 
ified from Ruan and Lloyd [28]. The reaction mixtures were made of 
50 nmol CDH, various concentrations of CMP-[~4C]NeuAc (36900 
cpm/nmol), 100 mM sodium cacodylate buffer, pH 6.5, 1% Triton 
CF-54, 8.33 mM MnC12 and 400 to 800/lg cellular proteins in a total 
volume of 120,ul. After various incubation periods at 37°C under gentle 
shaking, the reaction was stopped by addition of 120/tl ethanol. Un- 
reacted CMP-NeuAc and degradation products were removed by re- 
versed-phase chromatography on a C 18-bonded silica gel column. The 
eluted fraction was divided into two equivalent portions: the first one 
was dried and counted in a scintillation spectrometer after addition of 
Ultima-Gold (Packard, Meriden, CT, USA); the remaining portion was 
subjected to TLC as described above, followed by fluorography after 
spraying TLC plates with Enlightning (New England Nuclear, Paris), 
then exposure to X-ray films (Hyperfilm-MP, Amersham). 
2. 7. Ganglioside assay 
Gangliosides were assayed according to their sialic acid content by 
using Svennerholm's resorcinol method [29] as modified by Jourdian 
et al. [30]. 
2.8. Determination of glycosphingolipid content 
Glycosphingolipids were assayed by their sphingosine content using 
the fluorimetric method of Naoi et al. [31]. 
2.9. Protein assay 
Proteins were quantified using a colorimetric protein assay (Biorad, 
Ivry-sur-Seine, France) according to Bradford [32]. 
3. Results and discussion 
The parental  M4Be human melanoma cell line and its derived 
1C8 clone, both unable to give lung metastases, greatly differed 
from the metastatic T1 C3 clone by their glycosphingolipid pro- 
Table 1 
Distribution of gangliosides of high and low metastatic human mela- 
noma cells 
Ganglioside M4Be IC8 T 1 C3 
GM3 19.2%" 19.9% 79.2% 
GM2 5.8% 7.3% 6.2% 
9-OAcGD3 7.4% 10.0% 2.1% 
GD3 50.0% 44.5% 12.5% 
GD2 12.8% 9.4% traces 
GTlb 4.8% 8.9% traces 
Total lipid-bound sialic 
acid (,ug/g proteins) 1.88 + 0.02 1.91 + 0.02 0.48 + 0.01 
Total sphingoglycolipids 
(nmol/mgproteins) 11.07+0.03 11.69_+0.05 10.64_+0.05 
aValues are expressed in nmoles per cent nmoles of total gangliosides. 
Values of total sphingoglycolipids and total lipid-bound sialic acid are 
the mean + S.E. of three different assays. 
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Fig. 2. Time course of CMP-NeuAc: LacCer a2 3 sialyltransferase (GM3 synthase) activity in crude extracts of low (IC8) and high (TIC3) metastatic 
human melanoma cells. Sialyltransferase was assayed in duplicates at different incubation periods in the presence of 50 nmol LacCer and 32 nmol 
CMP-[lac]NeuAc. (A) Autoradiograms of the reaction products. GM3 indicates the migration of standard unlabeled GM3 (B) Kinetics of [~4C]NeuAc 
incorporation i to lipid-soluble components ( ee section 2). 
files. As shown in Fig. 1A (lanes a,b), the major gangliosides 
in M4Be and IC8 cells were identified as GM3, GM2, 9-0- 
AcGD3, GD3 and GD2. In contrast, the T1C3 cells almost 
exclusively contained GM3, with low amounts of GM2, 9-0- 
AcGD3 and GD3, and no GD2 (Fig. 1A, lane c; Table 1). 
Although GM3 represented the major ganglioside in these cells, 
its amount was about two to threefold lower than in M4Be and 
IC8 cells. In T1C3 cells only, a strong band in the zone of 
ceramide dihexoside: CDH was observed, with trace amounts 
ofceramide trihexoside: CTH (Fig. 1 B, lane c), which is synthe- 
sized from CDH by the transfer of an additional galactose. The 
accumulating CDH was identified as lactosylceramide (Lac- 
Cer), with no traces of galabiosylceramide, by the TLC mobility 
of the peracetylated derivative as previously described [33]. 
Thus, the defect in the ganglioside synthesis in the metastatic 
melanoma cells was accompanied by a concomitant accumula- 
tion of LacCer, which is the common precursor of the gangli- 
osides in the biosynthetic pathway known to exist in human 
melanoma cells [28]. Although T1C3 cells yielded fourfold less 
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Fig. 3. Determination f the apparent enzymatic parameters of GM3 
synthase from low (IC8) and high (T1C3) metastatic human melanoma 
clones. Complete incubation mixtures containing various concentra- 
tions of CMP-[~4C]NeuAc (S, substrate) as indicated, were incubated 
40 min at 37°C. Kinetic parameters Vmax and K m were calculated by 
linear egression from double reciprocal Lineweaver-Burke plots (1/V 
versus l/S). Km IC8 and TIC3 = 173/JM; Vma xIC8 -- 178 pmol/h/mg 
protein; Vm~ xT1C3 = 643 pmol/h/mg protein. 
gangliosides than M4Be and IC8 cells (Table 1), the amount of 
total glycosphingolipid was not different (11.07+0.03 nmol/mg 
protein). IC8 and T1C3 crude cell homogenates were assayed 
for CMP-NeuAc:LacCer a2,3 sialyltransferase (GM3 syn- 
thase, EC 2.4.99.9) activity in the presence of donor CMP- 
[laC]NeuAc and exogenous acceptor LacCer purified from 
human melanoma tumors [22]. The reaction velocity of the 
GM3 synthase activity increased linearly with incubation time 
(Fig. 2). In both cell clones, []4C]GM3 was synthetized (Fig. 
2A). However, a weak activity was seen in T1C3 cells, regard- 
less of the incubation time in the assay, in contrast to the high 
activity in IC8 cells (Fig. 2B). The apparent activity found in 
T1C3 cells was probably engendered by the high endogeneous 
LacCer content since, when LacCer was omitted in the assay, 
T1C3 cells synthesized GM3 in a similar ate (data not shown). 
GM3 synthase is weakly operative in metastatic melanoma 
cells, due to a low ability to transfer sialic acid to LacCer, rather 
than to a decrease in the affinity towards CMP-NeuAc sub- 
strate. In fact, when the apparent kinetic constants towards 
CMP-NeuAc substrate were estimated from the double reci- 
procal Lineweaver-Burke plots (Fig. 3), we found Vmax to be 
fourfold lower in T1C3 cells (178 pmol NeuAc/h/mg protein) 
than in IC8 cells (643 pmol NeuAc/hr/mg protein), whereas the 
apparent Km was similar (173/zM). 
Our results trongly suggest that the human melanoma cells 
which have potential to give lung metastases xhibit a deficient 
ganglioside biosynthesis. To have further information about 
such alterations of biosynthesis n the metastases, the glyco- 
sphingolipids were compared between IC8 and T1C3 mela- 
noma cells grown either as s.c. tumors or as lung metastases 
(Fig. 4). Although IC8 and T1C3 cells drastically differed in 
their glycosphingolipid profiles in culture, the same pattern as 
cultured IC8 was found in both IC8 and TIC3 when grown in 
subcutaneous tumors in rats. By contrast, the T1C3-induced 
lung metastases xhibited the same glycosphingolipid pattern 
as cultured T 1 C3 cells with GM3 as the most prominent gangli- 
oside accompanied by a strong accumulation of LacCer, 
whereas the tumor-free lungs from rats injected with IC8 cells 
contain exclusively GM3 without accumulation of neutral gly- 
cosphingolipid (Fig. 4), as in normal rat lungs (not shown). The 
rather simple ganglioside composition of the lung metastases 
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Fig. 4. Thin-layer chromatogram of gangliosides (A) and neutral glycosphingolipids (B) extracted from subcutaneous rat tumors (a,c) and related 
rat lungs (b,d) harvested three weeks after s.c. inoculation of low metastatic IC8 cells (a,b) or high metastatic T1C3 cells (c,d). In A, bands above 
GM3 are residual neutral glycosphingolipids. In B, GM3 and bands below are acidic glycolipid components. 
in contrast to the more complex patterns found in the s.c. 
tumors may be interpreted in terms of the well-known phenom- 
enon of heterogeneization along with the tumor growth [34]. 
Therefore, our data strongly suggest hat human melanoma 
cells which escape from the s.c. tumors to proliferate in the 
lungs are those which have a low activity o fGM3 synthase and 
only traces amont of GD2 and GD3. Our findings are quite 
consistent with the reported clinical outcome of melanoma pa- 
tients treated by immunotherapy using MAbs against GD2 and 
GD3. Indeed, such trials were shown to induce complete or 
partial regressions of primary tumors, whereas the effect was 
only weak on metastases [11 16]. 
Glycolipids may play a critical role in the interactions be- 
tween tumoral and host cells. In this respect, GM3 was recently 
described to interact with LacCer [35]. Thus, LacCer which is 
highly expressed on metastasizing cells could interact with 
GM3 in the lung parenchyma. The nearly total absence of 
disialogangliosides in highly metastatic cells is also a striking 
feature and we are currently investigating the relevance of GD3 
synthase in the onset of the metastatic spread of T 1 C3 cells. The 
recent cloning of GD3 synthase from melanoma cells by Nara 
et al. [36] shall offer valuable tools for such studies. 
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